STRUCTURAL CHARACTERISTICS OF 4 HUMAN HYBRIDOMA ANTIBODIES SPECIFIC FOR THE PP65 PROTEIN OF THE HUMAN CYTOMEGALOVIRUS AND THEIR RELATIONSHIP TO HUMAN RHEUMATOID FACTORS
Jd. Rioux et al., STRUCTURAL CHARACTERISTICS OF 4 HUMAN HYBRIDOMA ANTIBODIES SPECIFIC FOR THE PP65 PROTEIN OF THE HUMAN CYTOMEGALOVIRUS AND THEIR RELATIONSHIP TO HUMAN RHEUMATOID FACTORS, Molecular immunology, 31(8), 1994, pp. 585-597
Four human hybridoma antibodies directed against the human cytomegalov
irus (CMV) were characterized with respect to their immunoglobulin gen
e usage and expression of rheumatoid factor (RF) associated idiotypes
and variable region epitopes. The aims of these experiments were: (I)
to characterize the immunoglobulin gene usage of four antibodies direc
ted against a single protein of a human pathogen; and (2) to examine h
ow this humoral response may be linked to the production of RFs, autoa
ntibodies found in the majority of patients with rheumatoid arthritis
(RA). All four anti-CMV antibodies were of the gamma heavy chain isoty
pe and were specific for the immunodominant 65 kDa viral matrix phosph
oprotein (pp65). The four anti-pp65 antibodies expressed different lig
ht (L) and heavy (H) chain variable region gene combinations. These we
re: V(lambda)1/V(H)3, V(lambda)1/V(H)3, V(lambda)1/V(H)4 and V(lambda)
3/V(H)3, respectively for the HCV-2, HCV-3, HCV-63 and HCV-65 hybridom
a cell lines. Although none had RF activity, each of these antibodies
expressed a unique set of RF-associated determinants, implying differe
nt three-dimensional configurations of the variable regions of these a
ntibodies. The HCV-2 antibody, however, had the most extensive similar
ities to human RFs since it not only expressed the greatest number of
RF-associated determinants but also had a protein sequence that was ve
ry homologous to RFs of the ''Po'' idiotypic family. Furthermore, pred
icted germline gene usage by anti-CMV antibodies and RFs suggest that
some are encoded by identical or similar genes and that the different
specificities are achieved by somatic mutations in the L and H chain c
omplementarity determining regions (CDRs) and genetic diversity in the
H chain CDR3.